Ticlopidine-carbamazepine interaction in a coronary stent patient.
Neurological symptoms occurred in association with increased carbamazepine levels because of a probable drug interaction between ticlopidine and carbamazepine in an epileptic patient undergoing coronary stenting. Physicians should be aware of this possible drug interaction.
Brown
R I
RI
Royal Columbian Hospital, New Westminster, British Columbia.
Cooper
T G
TG
D000368:Aged; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D003327:Coronary Disease / Q000150:complications / Q000628:therapy*; D004347:Drug Interactions; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D015607:Stents; D013988:Ticlopidine / Q000009:adverse effects* / Q000627:therapeutic use
D000927:Anticonvulsants; D010975:Platelet Aggregation Inhibitors; D002220:Carbamazepine; D013988:Ticlopidine